A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection
NCT02707952
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
295
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis C Virus
Hepatitis C Virus
Interventions
DRUG:
ABT-493/ABT-530
DRUG:
OBV/PTV/r
Sponsor
AbbVie